Osimertinib-induced erythema dyschromicum perstans
Osimertinib-induced erythema dyschromicum perstans is a benign but striking phenomenon that does not require cessation of the causative drug. Clinically, it mimics lichen planus pigmentosus, pigmented contact dermatitis and fixed drug eruption. Clinicopathological correlation can distinguish these differentials.
Authors
- Vanessa Ziying Lim
- Nicholas Seng-Geok Goh
- Valencia Long (ORCID: https://orcid.org/0000-0002-1346-9903)
Institutions
- National Skin Centre (SG)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2025-07-30
- DOI
- https://doi.org/10.1093/ced/llaf351
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00